Epinephrine biosynthesis pathway

The epinephrine biosynthesis pathway is a fundamental metabolic sequence responsible for the production of the catecholamine hormone and neurotransmitter epinephrine from the amino acid L-tyrosine. This pathway primarily functions within the chromaffin cells of the adrenal medulla and specific adrenergic neurons in the central nervous system (StatPearls: NBK507716). It consists of four sequential enzymatic steps: the hydroxylation of tyrosine to L-DOPA by tyrosine hydroxylase, the decarboxylation of L-DOPA to dopamine by aromatic L-amino acid decarboxylase, the hydroxylation of dopamine to norepinephrine by dopamine beta-hydroxylase, and finally the methylation of norepinephrine to epinephrine by phenylethanolamine N-methyltransferase (UniProt: P07101, P20711, P09172, P11086). Epinephrine is a key mediator of the sympathetic nervous system's fight-or-flight response, exerting widespread effects on the cardiovascular and metabolic systems. Dysregulation or overactivity of this pathway is a hallmark of conditions such as pheochromocytoma and paraganglioma, which lead to secondary hypertension and cardiac arrhythmias (NIH: Genetic and Rare Diseases Information Center). Pharmacological intervention typically involves the use of enzyme inhibitors, such as metyrosine, which targets the rate-limiting enzyme tyrosine hydroxylase to decrease total catecholamine production in patients with catecholamine-secreting tumors (PubChem: CID 4212). Other drugs, like carbidopa, inhibit peripheral decarboxylation to modulate the pathway for neurological benefits in Parkinson's disease (PubChem: CID 34359).

Other names

Adrenaline biosynthesis pathwayCatecholamine biosynthetic pathwayL-Tyrosine to Epinephrine pathway

Inhibition of specific enzymes within the biosynthetic cascade, such as tyrosine hydroxylase or dopamine beta-hydroxylase, to reduce the production of downstream catecholamines like norepinephrine and epinephrine.